Testosterone replacement therapy (TRT) is widely used in the management of symptomatic hypogonadism. Benefits include improved libido, mood stabilization, increased muscle mass, and enhanced bone density.
However, therapy requires careful monitoring due to potential risks such as erythrocytosis, prostate enlargement, and cardiovascular concerns. Baseline and periodic evaluation of hematocrit, prostate-specific antigen (PSA), and lipid profile are recommended.
Professional recommendations from the Endocrine Society emphasize individualized treatment and avoidance of unnecessary supplementation.
Balanced risk assessment ensures safe and effective erotic hormone replacement strategies.
Leave a Reply